News|Videos|May 22, 2026

Psychiatric Times Brings Clinicians the Latest Psychopharmacology Insights From ASCP 2026

John J. Miller, MD, Psychiatric Times editor in chief, looks forward to learning and sharing the late-breaking science, expert interviews, and new podcast conversations in psychopharmacology.

CONFERENCE REPORTER

The latest developments in psychopharmacology will take center stage at the upcoming 2026 American Society for Clinical Psychopharmacology (ASCP) Annual Meeting in Miami, Florida, and Psychiatric Times will be there to bring clinicians the highlights. Coverage will include reporting on late-breaking posters and scientific sessions, interviews with leading experts, and new podcast conversations focused on issues that influence psychiatric care every day.

In a recent interview, Psychiatric Times Editor in Chief John J. Miller, MD, discussed the publication’s plans for on-site coverage, highlighting opportunities to share insights from scientific presentations, conversations with experts, and multimedia programming designed to translate meeting takeaways into practical information for practicing clinicians.

ASCP Annual Meeting Coverage Will Spotlight Emerging Science and Clinical Perspectives

Miller expressed enthusiasm about attending the meeting alongside the Psychiatric Times team, describing the event as an important opportunity to engage with leaders in psychopharmacology and learn about developments shaping the future of psychiatric treatment.

“I am really excited to share that this year we at Psychiatric Times are joining the American Society for Clinical Psychopharmacology’s annual meeting in Miami, Florida,” Miller said.

Coverage from the meeting will include highlights from late-breaking posters and scientific sessions, as well as discussions with experts about psychopharmacology issues that affect everyday patient care. According to Miller, the event offers an opportunity to hear directly from investigators, learn about therapies in development, and better understand advances occurring across the field.

As both a biochemist and psychopharmacologist, Miller reflected on his longstanding interest in the scientific foundations of psychiatric treatment and the continued expansion of therapeutic options available to clinicians.

“I’m excited to hear the lectures, to learn what’s in the pipeline, to talk to the experts, to see colleagues,” he said.

Bringing Conversations With Psychopharmacology Leaders to the Psychiatric Times Audience

A key component of the publication’s coverage strategy will be direct conversations with recognized leaders in psychopharmacology. Miller noted that these discussions are intended to help clinicians stay informed about emerging research and evolving treatment approaches.

“I’m really excited to have some conversations with the titans in this area that we will be sharing with you,” Miller said. “To help disseminate what’s happening in the pipeline [and] the cutting edge.”

Those interviews will become part of Talking With Titans, Miller’s podcast series that features in-depth conversations with influential figures in psychiatry and psychopharmacology. The recordings are expected to provide clinicians with additional context surrounding developments presented during the meeting and perspectives from experts actively shaping the field.

New Psychopharm Today Episodes to Expand Meeting Coverage

In addition to Talking With Titans, the meeting will also serve as a venue for recording episodes of Psychopharm Today, a new collaborative initiative between Psychiatric Times and ASCP.

Together, these multimedia efforts are intended to complement the publication’s written reporting from the conference, providing multiple ways for clinicians to engage with key discussions and emerging scientific developments presented during the meeting.

For Miller, an important goal of the coverage is ensuring that insights from conference presentations and expert discussions reach practicing psychiatrists who may not be able to attend in person.

He emphasized the value of bringing important developments directly to the publication’s audience, describing the effort as an opportunity to “share the joy” of discovery and learning occurring within the field.

“Stay tuned and be on the lookout for these videos as they roll out,” Miller said.

Miller also encouraged attendees who will be present in Miami to connect with the Psychiatric Times team during the meeting.

“Maybe I’ll see you there,” he said. “Please stop by and I’d love to say hello.”